Following a request from the European Commission to deliver an opinion on the nutrient source, magnesium citrate malate, the Authority adopted a scientific opinion on the bioavailability of magnesium from magnesium citrate malate when added for nutritional purposes to food supplements [EFSA Journal 2018;16(12):5484.]. The Authority concluded that magnesium citrate malate is a source from which magnesium is bioavailable. The assessment of the bioavailability of a nutrient source is of relevance to its safety assessment as explained by the Authority in its guidance document ‘Guidance on safety evaluation of sources of nutrients and bioavailability of nutrient from the sources’ [EFSA Journal 2018;16(6):5294.]. The Authority explains that its approach to evaluating the bioavailability of a nutrient source is by using comparative studies that consider the bioavailability of the chemical forms of the nutrient that are already on the positive lists in the relevant legislation. The Authority further explains that the classification of the bioavailability of a nutrient source as being equivalent, higher or lower than a reference source has implications for the safety of the source at the proposed uses and use levels and with respect to relevant health-based guidance values, such as the tolerable upper intake level (UL) for the nutrient itself.
Recital 8, Regulation (EU) 2021/418
In force